v3 Template
T

Teitur Trophics

Biotechnology / Life Sciences ~460 employees
Founded
--
Employees (Est.)
~460
23 leaders known
Total Funding
$28.0M
Funding Rounds
1
Last Funding
2023-03-14

About Teitur Trophics

Teitur Trophics is a biotech company based in Aarhus, Denmark, dedicated to developing new treatments for neurodegenerative diseases. Named after the Old Norse word for 'happiness,' the company reflects a deep commitment to preserving meaningful life moments and improving the quality of life for those affected by conditions like Parkinson's disease, Huntington's disease, and Frontotemporal dementia. Founded as a spin-out from Aarhus University, Teitur focuses on creating innovative therapies to slow or halt disease progression.

Products & Services

TT-P34:A lead, first-in-class cyclic peptide drug candidate designed as a potential disease-modifying therapy for neurodegenerative disorders, including Parkinson's disease. Administered subcutaneously, it targets mitochondrial and lysosomal dysfunction to preserve neuronal function and survival.
Pipeline for Neurodegenerative Diseases:Innovative peptides targeting Parkinson's disease, Huntington's disease, Frontotemporal dementia, and other related conditions, focusing on multiple aspects of cell degeneration.
Hearing Loss Therapy (RE-HEAR Project):A collaborative project to advance peptide-based therapeutics for sensorineural hearing loss, targeting hidden and age-related hearing loss through the SorCS2 receptor pathways.

Specialties

Neurodegenerative disease therapies Cyclic peptide development Disease-modifying treatments Parkinson's disease research Huntington's disease research Frontotemporal dementia research Hearing loss therapies Biomarker development SorCS receptor targeting

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series A
T: -
FT: Series A
A: 28000000
MR: -
FA: €28M
FAN: 28000000
D: 2023-03-14
FD: 2023-03-14
5 investors
Series A Latest
2023-03-14
$28.0M
5 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

N

Nils Anton Berglund

Business Development Lead

M

Maya Bjørnholt Tyssøy

Office Manager & Executive Assistant

M

Mia Aaboe Jørgensen

Preclinical & Clinical Project Manager

S

Sanne Nordestgaard

Laboratory Technician

A

Anne Kathrine Nissen Pedersen

Senior Scientist

E

Emil Gregersen

Senior Scientist

View 20 more team members with Pro

Unlock Full Team Directory

Recent News

Teitur Trophics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Life Sciences
Company Size
~460 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro